{
    "2018-03-01": [
        [
            {
                "time": "",
                "original_text": "速读社丨新基多发性硬化症药物ozanimod遭FDA拒绝",
                "features": {
                    "keywords": [
                        "新基",
                        "多发性硬化症",
                        "药物",
                        "ozanimod",
                        "FDA",
                        "拒绝"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}